netFormulary NHS
Demonstration Formulary
 Search
 Results

Looking for Rituximab found 22 matches

   


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE 193: Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia (08.01.03)
link in drug section NICE TA137: Lymphoma (follicular non-Hodgkins) - rituximab (08.02.03)
link in drug section NICE TA174: Leukaemia (chronic lymphocytic, first line) - rituximab (08.02.03)
link in drug section NICE TA193: Leukaemia (chronic lymphocytic, relapsed) - rituximab  (08.02.03)
link in drug section NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
link in subsection NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
link in drug section NICE TA195: Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (08.02.03)
link in drug section NICE TA206: Bendamustine for the treatment of indolent (low grade) non-Hodgkins lymphoma that is refractory to rituximab (terminated appraisal) (08.01.01)
link in drug section NICE TA226: Rituximab for the first-line maintenance treatment of follicular non-Hodgkins lymphoma (08.02.03)
link in drug section NICE TA243: Rituximab for the first-line treatment of stage III-IV follicular lymphoma: (review of NICE technology appraisal guidance 110) (08.02.03)
link in drug section NICE TA308: Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis (08.02.03)
link in drug section NICE TA308: Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis (10.01.03)
link in drug section NICE TA472: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab (08.02.03)
link in drug section NICE TA472: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab (08.01.01)
link in drug section NICE TA561: Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia (08.01.05)
link in drug section NICE TA627: Lenalidomide with rituximab for previously treated follicular lymphoma (08.02.04)
link in drug section NICE TA629: Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab (08.02.03)
link in drug section NICE TA649: Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma (08.01.05)
link in drug section NICE TA65: Rituximab for aggressive non-Hodgkins lymphoma (08.02.03)
link in drug section TA174: Rituximab for the first-line treatment of chronic lymphocytic leukaemia (08.01.03)
link in drug section TA174: Rituximab for the first-line treatment of chronic lymphocytic leukaemia (08.01.01)
link in drug section TA193: Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia (08.01.01)


 
netFormulary